Skip to main content

Advertisement

SpringerLink
Log in

Clinical application of ultrasound-guided percutaneous microwave ablation in the treatment of T1aN0M0 stage renal carcinoma

  • Original Article
  • Published:
Journal of Medical Ultrasonics Aims and scope Submit manuscript

Abstract

Purpose

Evaluation of clinical application of ultrasound-guided percutaneous microwave ablation treatment for T1a renal carcinoma.

Methods

Analysis of the clinical data from 31 patients with T1aN0M0 stage renal carcinoma who underwent ultrasound-guided percutaneous microwave ablation in the Department of Ultrasound of China-Japan Union Hospital of Jilin University between March 2010 and June 2014.

Results

All of the 31 patients were treated with ablation only once: 96.8% (30/31) of patients had no local recurrence or distant metastasis after ablation. One (3.2%) patient had local tumor recurrence 6 months after surgery and underwent a second microwave ablation. According to the results of 2 years of follow-up re-examinations, no further recurrence or distant metastasis was found. Moreover, 90.3% (28/31) of the patients had no complications with normal ranges of preoperative and postoperative serum creatinine and urea nitrogen levels. Complications were found in 9.7% (3/31) of the patients: one case of transient hematuria, one case of perirenal hematoma, and one case of cholecystitis; the symptoms were resolved with symptomatic treatment.

Conclusion

Ultrasound-guided percutaneous microwave ablation is a safe and effective micro-invasive therapy for T1a renal cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32.

    Article  PubMed  Google Scholar 

  2. Ridge CA, Pua BB, Madoff DC. Epidemiology and staging of renal cell carcinoma. Semin Intervent Radiol. 2014;31:3–8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hancock SB, Georgiades CS. Kidney Cancer. Cancer J. 2016;22:387–92.

    Article  PubMed  Google Scholar 

  4. Dunnick NR. Renal cell carcinoma: staging and surveillance. AbdomRadiol (NY). 2016;41:1079–85.

    Google Scholar 

  5. Pham D, Kron T, Bressel M, et al. Image guidance and stabilization for stereotactic ablative body radiation therapy (SABR) treatment of primary kidney cancer. Pract Radiat Oncol. 2015;5:e597–605.

    Article  PubMed  Google Scholar 

  6. Ghandour RA, Danzig MR, McKiernan JM. Renal cell carcinoma: risks and benefits of nephron-sparing surgery for T1 tumors. Adv Chronic Kidney Dis. 2015;22:258–65.

    Article  PubMed  Google Scholar 

  7. Sato T, Iguchi T, Hiraki T, et al. Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients. Jpn J Radiol. 2017;35:61–7.

    Article  PubMed  Google Scholar 

  8. Georgiades C, Rodriguez R. Renal tumor ablation. Tech Vasc Interv Radiol. 2013;16:230–8.

    Article  PubMed  Google Scholar 

  9. Vetterlein MW, Jindal T, Becker A, et al. Small renal masses in the elderly: contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategies. Investig Clin Urol. 2016;57:231–9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lin Y, Liang P, Yu XL, et al. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with a solitary kidney. Urology. 2014;83:357–63.

    Article  PubMed  Google Scholar 

  11. Lin Y, Liang P, Yu XL, et al. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with renal dysfunction. Int J Hyperthermia. 2016;15:1–6.

    Google Scholar 

  12. Zhang M, Liang P, Cheng ZG, et al. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract. Int J Hyperthermia. 2014;30:134–41.

    Article  PubMed  Google Scholar 

  13. Ahmed M. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update: supplement to the consensus document. J Vasc Interv Radiol. 2014;25:1706–8.

    Article  PubMed  Google Scholar 

  14. Crepel M, Jeldres C, Perrotte P, et al. Nephron-sparing surgery is equally effective to radical nephrectomy for T1bN0M0 renal cell carcinoma: a population-based assessment. Urology. 2010;75:271–5.

    Article  PubMed  Google Scholar 

  15. Hernández JI, Cepeda MF, Valdes F, et al. Microwave ablation: state-of-the-art review. Onco Targets Ther. 2015;8:1627–32.

    PubMed  PubMed Central  Google Scholar 

  16. Vroomen LGPH, Petre EN, Cornelis FH, et al. Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: what are the differences? Diagn Interv Imaging. 2017;98:609–17.

    Article  CAS  PubMed  Google Scholar 

  17. Isfort P, Penzkofer T, Mahnken AH. Efficacy of antegrade pyeloperfusion to protect the renal pelvis in kidney microwave ablation using an in vivo swine model. Invest Radiol. 2013;48:863–8.

    Article  PubMed  Google Scholar 

  18. Saeednejad Zanjani L, Madjd Z, Abolhasani M, et al. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma. Exp Mol Pathol. 2017;103:218–28.

    Article  CAS  PubMed  Google Scholar 

  19. Zhao X, Wang W, Zhang S, et al. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdom Imaging. 2012;37:885–91.

    Article  PubMed  Google Scholar 

  20. Carrafiello G, Mangini M, Fontana F, et al. Single-antenna microwave ablation under contrast-enhanced ultrasound guidance for treatment of small renal cell carcinoma: preliminary experience. Cardiovasc Intervent Radiol. 2010;33:367–74.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was funded by the Finance Department of Jilin Province (No. SCZSY201618).

Author information

Authors and Affiliations

  1. Department of Ultrasound, China-Japan Union Hospital of Jilin University, Changchun, 130000, Jilin, China

    Guoqing Sui, Qiang Luo, Jiarui Du, Dengke Teng & Hui Wang

Authors
  1. Guoqing Sui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qiang Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiarui Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dengke Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hui Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hui Wang.

Ethics declarations

Ethical statements

This study was conducted in accordance with the declaration of Helsinki. This study was conducted with approval from the Ethics Committee of Jilin University. Written informed consent was obtained from all participants.

Conflict of interest

The authors declare that they have no conflicts of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sui, G., Luo, Q., Du, J. et al. Clinical application of ultrasound-guided percutaneous microwave ablation in the treatment of T1aN0M0 stage renal carcinoma. J Med Ultrasonics 46, 217–222 (2019). https://doi.org/10.1007/s10396-018-0918-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10396-018-0918-6

Keywords

Search

Navigation